How fast does acyclovir work for RSV?
Acyclovir is an antiviral used for herpes viruses (such as HSV and VZV). For RSV (respiratory syncytial virus), acyclovir is not a standard or proven treatment, so there is no reliable “how fast” timeline for clinical improvement the way there is for RSV-specific therapies.
If acyclovir is being considered for an infant or child with RSV, it’s usually because clinicians suspect another virus (for example HSV) or a mixed/uncertain diagnosis rather than treating RSV itself. In those cases, the “speed” of improvement would depend on the actual condition being treated, not RSV.
What treatments are actually used for RSV (and how quickly do they help)?
For most RSV cases, treatment is supportive (fluids, oxygen if needed, suctioning, and monitoring). Supportive care timing depends on severity; breathing symptoms can improve over hours to a couple of days when oxygen needs are reduced and feeding stabilizes. The pace varies a lot by how sick the patient is at presentation.
When should you expect worse vs better in RSV?
RSV typically causes the worst breathing symptoms in the first several days of illness, then gradually improves. If symptoms are worsening (increasing work of breathing, poor feeding, dehydration, or low oxygen), that usually triggers reassessment and possible hospitalization—rather than switching to off-label antiviral treatment.
When is hospitalization needed for RSV?
Clinicians generally consider hospital care when a child has signs of respiratory failure risk, such as persistent low oxygen, significant breathing effort, inability to feed, dehydration, apnea, or very young age with rapid deterioration.
Quick check: do you mean acyclovir or a different drug?
If you meant a different antiviral or medicine sometimes confused with acyclovir (or if you saw an “acyclovir RSV” claim online), the timing could change completely. If you share the patient age, what formulation you’re asking about (oral vs IV), and the exact medication name on the label (and dose if you have it), I can give a more specific, medically relevant expectation based on the right drug.
Source
- DrugPatentWatch.com – acyclovir drug patent/exclusivity information